The Geographical Structure of Epidemics is an accessible and in-depth examination of the ways in which geographical and environmental concepts can enhance our knowledge of the ways in which epidemics spread through human populations, written by a leading expert with over 30 years' experience in the field.

Societies in transition are often faced with new settings and/or new diseases that require a response in order for the affected group to thrive or survive. A lack of effective response by a transitional population to a new pathogen can lead to the group's disintegration. A stark example of this, historically, is the decline of Native American civilizations with the arrival of European colonists in the sixteenth and seventeenth centuries. The transitional response mechanism has been a neglected topic in anthropology until the publication of this book. In a broad selection of nineteen essays by distinguished researchers, the epidemiology and health status of prehistoric, historical, and present day populations in transition are thoroughly explored.

Different models--biomedical, ethnomedical, ecological, and politicoeconomic--are used to illustrate the effects of transition on the health of human populations throughout the world. Swedlund and Armelagos have compiled and arranged these essays into three parts: genetic and evolutionary perspectives; infectious disease and nutrition in temporal perspective; and social epidemiology. Some of the topics studied in the essays include: disease and evolution in Amerindian populations; health and disease in prehistoric transitional peoples; mortality and morbidity consequences of nutritional variation in early child growth; and social support and mortality in post-transition populations. This insightful book will provide a vital perspective for medical anthropologists, development specialists, epidemiologists, and health professionals, as well as for graduate students in related course areas.

This books provides an essential study of communicable diseases, by integrating the diagnosis, treatment and cure of communicable diseases in developing countries with the practical aspects of delivery of these services to the public.

This title critically reviews old and new literature, help to create greater awareness of the disease in the US and helps in the evaluation of certain epidemiological and public health issues.

During the first half of the 20th century, Chagas disease was assumed to be absent from the U.S. and considered an exotic disease, until the first two indigenous cases were discovered, almost simultaneously, in Texas, 1955. Since that time four indigenous cases have been documented in several places in the country. Although the disease is still considered uncommon in the US, this disease is not longer an exclusive Latin American illness.

Physicians in the US are often unaware of the characteristics of the diseases, and are likely overlooking locally acquired cases. The influx of an estimated 300,000 Latin American immigrants with the Chagas parasite means that there is an urgent need for physicians and public health officials to become aware.
Helps to create greater awareness of Chagas disease in the USAHelps to evaluate epidemiological and public health issuesFacilitates accurate and necessary future public health interventions

Therearemanygoodepidemiologytextbooksonthemarket,butmostoftheseare addressedtostudentsofpublichealthorpeoplewhodoclinicalresearchwithe- demiologicmethods. Thereisaneedforashortintroductiononhowepidemiologic methodsareusedinpublichealth,geneticandclinicalepidemiology,becausehealth professionalsneedtoknowbasicepidemiologicmethodscoveringetiologicaswell asprognosticfactorsofdiseases. Theyneedtoknowmoreaboutmethodologythan introductorytextsonpublichealthhavetooffer. Insomehealthfaculties,epidemiologyisnotevenpartoftheteachingcurri- lum. Webelievethistobeaseriousmistake. Medicalstudentsarestudentsofall aspectsofdiseasesandhealth. Withoutknowingsomethingaboutepidemiologythe cliniciansandotherhealthprofessionalscannotreadagrowingpartofthesci- ti cliteratureinanyreasonablycriticalwayandcannotnavigateintheworldof "evidence-basedmedicineandevidence-basedprevention. "Withoutskillsine- demiologicmethodologytheyareinthehandsofexpertsthatmaynotonlyhavean interestinhealth. Some health professionals may believe that only common sense is needed to conductepidemiologicalstudies,butthescienti cliteratureandthepublicdebate onhealthissuesindicatethatcommonsenseisofteninshortsupplyandmaynot thrivewithoutsomeformaltraining. Epidemiologic methods play a key role in identifying environmental, social, and genetic determinants of diseases. Clinical epidemiology addresses the tr- sitionfromdiseasetohealthortowardmortalityorsocialormedicalhandicaps. Publichealthepidemiologyaddressesthetransitionfrombeinghealthytobeingnot healthy. Descriptiveepidemiologyprovidesthediseasepatternthatisneededtolook athealthinabroadperspectiveandtosettheprioritiesright. Epidemiologyisabasic scienceofmedicinewhichaddresseskeyquestionssuchas"Whobecomesill?"and "Whatareimportantprognosticfactors?"Answerstosuchquestionsprovidethe basisforbetterpreventionandtreatmentofdiseases. Many people contributed to the writing of this book: medical students in Denmark,studentsofepidemiologyattheIEAEEPEsummercourseinFlorence, Italy,andstudentsofpublichealthinLosAngeles. Withouttechnicalassistance v vi Preface fromGitteNielsen,JenadeShelley,NinaHoheandPamMasangkaythebookwould neverhavematerialized. LosAngeles,California JornOlsen Odense,Denmark KaareChristensen IowaCity,Iowa JeffMurray Stockholm,Sweden AndersEkbom Contents Part I Descriptive Epidemiology 1 Measures of Disease Occurrence ...3 IncidenceandPrevalence ...4 Incidence...6 RatesandDynamicPopulations ...7 CalculatingObservationTime...9 Prevalence,Incidence,Duration ...10 MortalityandLifeExpectancy ...11 LifeExpectancy ...12 References...13 2 Estimates of Associations ...15 3 Age Standardization...19 4 Causes of Diseases ...23 References...28 5 Descriptive Epidemiology in Public Health...29 GraphicalModelsofCausalLinks ...33 References...35 6 Descriptive Epidemiology in Genetic Epidemiology...37 OccurrenceDatainGeneticEpidemiology ...37 ClusteringofTraitsandDiseasesinFamilies ...38 TheOccurrenceofGeneticDiseases ...40 References...41 7 Descriptive Epidemiology in Clinical Epidemiology...43 SuddenInfantDeathSyndrome(SIDS)...44 CytologicalScreeningforCervixCancer ...45 ChangesinTreatmentofJuvenileDiabetes ...46 References...47 vii viii Contents Part II Analytical Epidemiology 8 Design Options...51 CommonDesignsUsedtoEstimateAssociations...51 EcologicalStudy ...52 Case-ControlStudy...54 CohortStudy ...5 5 ExperimentalStudy ...56 Reference ...57 9 Follow-Up Studies ...59 TheNon-experimentalFollow-Up(Cohort)Study ...59 StudyingRiskasaFunctionofBMI ...60 LongitudinalExposureData...62 DifferentTypesofCohortorFollow-UpStudies...63 10 Case-Control Studies...67 Case-CohortSampling ...69 DensitySamplingofControls...69 Case-Non-caseStudy...71 PatientControls ...72 SecondaryIdenti cationoftheSourcePopulation ...74 Case-ControlStudiesUsingPrevalentCases...74 WhentoDoaCase-ControlStudy? ...77 References...78 11 The Cross-Sectional Study...79 12 The Randomized Controlled Trial (RCT) ...81 Reference ...

"Electrical Disease of the Heart, 2nd Edition, volume 2, " covers the diagnostic and treatment options available in the management of electrical diseases and with its companion volume provides the latest developments in the field of experimental and clinical cardiac electrophysiology, genetics, pharmacology and interventional therapies of various clinical arrhythmogenic entities. This bookis highly relevant to a broad audience, ranging from medical and graduate students, to clinicians and scientists."

This book on Infectious Disease Informatics (IDI) and biosurveillance is intended to provide an integrated view of the current state of the art, identify technical and policy challenges and opportunities, and promote cross-disciplinary research that takes advantage of novel methodology and what we have learned from innovative applications. This book also fills a systemic gap in the literature by emphasizing informatics driven perspectives (e.g., information system design, data standards, computational aspects of biosurveillance algorithms, and system evaluation). Finally, this book attempts to reach policy makers and practitioners through the clear and effective communication of recent research findings in the context of case studies in IDI and biosurveillance, providing "hands-on" in-depth opportunities to practitioners to increase their understanding of value, applicability, and limitations of technical solutions. This book collects the state of the art research and modern perspectives of distinguished individuals and research groups on cutting-edge IDI technical and policy research and its application in biosurveillance. The contributed chapters are grouped into three units. Unit I provides an overview of recent biosurveillance research while highlighting the relevant legal and policy structures in the context of IDI and biosurveillance ongoing activities. It also identifies IDI data sources while addressing information collection, sharing, and dissemination issues as well as ethical considerations. Unit II contains survey chapters on the types of surveillance methods used to analyze IDI data in the context of public health and bioterrorism. Specific computational techniques covered include: text mining, time series analysis, multiple data streams methods, ensembles of surveillance methods, spatial analysis and visualization, social network analysis, and agent-based simulation. Unit III examines IT and decision support for public health event response and bio-defense. Practical lessons learned in developing public health and biosurveillance systems, technology adoption, and syndromic surveillance for large events are discussed. The goal of this book is to provide an understandable interdisciplinary IDI and biosurveillance reference either used as a standalone textbook or reference for students, researchers, and practitioners in public health, veterinary medicine, biostatistics, information systems, computer science, and public administration and policy.

The health and economic devastation caused by COVID-19 has revealed that most countries’ national health systems are inadequate to cope with pandemics. These are global challenges that call for global responses. At the heart of this book is a bold new proposal to create a global pandemic playbook that can be quickly deployed when the next pandemic strikes. Countries and their experts must collaborate to create early warning systems, preparedness, prevention, responses and containment. But who should pay the cost? Anne Kabagambe, a former Executive Board director for the World Bank Group, explores the options, and argues that to fail to learn from COVID-19 and neglect to create a global playbook now would cost far more when the next pandemic strikes.

This edited collection shows how the spread of HIV infection has been followed, represented, and managed in nine countries between 1982 and 1988. The countries cited in this study have been chosen to emphasize contrasts in the social and epidemiological profiles of AIDS, and to suggest the diversity of the problems constituted by HIV/AIDS in different national contexts. The juxtaposition of sequences of national response will raise questions about the range of policy options actually available to political and social policy-makers in a given context, and will invite further examination of the factors determining the acceptance or rejection of specific measures. Following the introduction, which outlines the choices that national governments confront in formulating AIDS policies, the successive chapters cover the reactions to HIV/AIDS in the United States, Brazil, France, Belgium, West Germany, Italy, Poland, Australia, and Africa. The final chapter compares the patterns of national response, identifies their common and divergent features, and points out tensions in policy-making caused by current changes in the spread of infection and in the understanding of the virus. This book makes informative reading for those who want to learn more about international variation in the political, social, and economic aspects of the AIDS epidemic.

A unique study of how syphilis, better known as the French disease in the sixteenth and seventeenth centuries, became so widespread and embedded in the society, culture and institutions of early modern Venice due to the pattern of sexual relations that developed from restrictive marital customs, widespread migration and male privilege.

This book describes the molecular biology, pathogenesis, epidemiology, and potential strategies for control of chikungunya virus (CHIKV) infection. It offers insight into the structure and functions of CHIKV proteins as they relate to host response, interaction with the arthropod vector, and vaccination. A detailed account of both the epidemiological outlook and the clinical syndrome of CHIKV infection is provided. The complex host-virus interaction and the signaling pathways that mediate such interactions are also covered. Throughout the book, graphics and charts are used to provide stimulating discussion on important findings in the field of chikungunyalogy. The chapters are written with a global perspective by experts of CHIKV from around the world. This project is especially significant given that CHIKV is a pathogen of worldwide public health concern. Although the presence of CHIKV infection is not global yet, worldwide dissemination is predicted in the future due largely to the lack of effective treatment/therapy, efficient control of transmission, and knowledge about mechanisms of pathogenesis. Additionally, globalization of CHIKV is predicated on its mode of dissemination (mosquito vector) and cross border travel and migration.

Epidemiology and Demography provides practical guidance on planning and implementing surveillance and investigation of disease and disease outbreaks. Exploring contributing factors to the dynamics of disease transmission and the identification of population risks, it also includes a discussion of ehtics in epidemiology and demography including important issues of privacy vs. public safety. With a chapter on H1N1 and Bird flu, this book will be important for students and professionals in public health and epidemiology.

Focuses on the techniques of surveillance and investigation of disease

Includes biostatistics and analysis techniques

Explores the ethics of disease studies

Includes chapter discussing H1N1 and Bird Flu

Population growth and global health disparities for many reproductive and perinatal outcomes are but a few of the pressing issues facing public health today. Despite growing interest in the field, formal training in reproductive and perinatal epidemiology remains limited, with few available textbooks aimed at providing an overview of the field. In response to this need, faculty from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and CIHR's Institute of Human Development, Child and Youth Health (IHDCYH) developed an intensive, competitive, Summer Institute in Reproductive and Perinatal Epidemiology. The curriculum of this Summer Institute has been developed into a textbook to provide students and researchers with a working knowledge of the substantive and methodologic issues underlying reproductive and perinatal epidemiology.
Reproductive and Perinatal Epidemiology offers a core curriculum that addresses the epidemiology of major reproductive and perinatal outcomes. From human fecundity to birth and neonatal outcomes, the subject is approached from as international a perspective as possible, and the unique methodologic issues underlying each outcome are discussed. Developed by leading researchers in collaboration with their students in response to their needs and concerns, this is the definitive textbook on the subject.

This edited volume concerns a group of devastating neurological disorders that share a common pathological mechanism, namely the aggregation and deposition of insoluble, proteinaceous lesions, termed 'amyloid'. Examples of cerebral amyloid disorders include common neurodegenerative diseases like Alzheimer's disease-related dementia and Parkinson's disease, as well as other less prevalent conditions like Huntington's disease, cerebral amyloid angiopathy and the transmissible prion disorders. A disease-modifying therapeutic agent is still lacking for all these diseases, and there are no approved therapies that target amyloid formation directly. Nevertheless, a large and complex group of natural aromatic compounds known as polyphenols are rapidly emerging as potentially potent anti-amyloidogenic agents. This book collectively presents a considerable body of experimental and epidemiological evidence from peer-reviewed scientific publications that support a role for natural compounds and herbal extracts in the chemoprevention and therapy of amyloidogenic disorders. Each contribution is written by scientific experts in the relevant field; chapters are devoted to Mediterranean diet and olive oil phenols, traditional Chinese medicine, herbal extracts, polyphenols (with a particular emphasis on epigallocatechin-3-gallate) and bi-flavonoids, amongst others. The topic of this book is relevant to a wide audience, from academia and university students in the biological and chemical sciences, to physicians and allied health professionals, as well as people working in the nutraceutical industry.

This book gives an up-to-date analysis of the epidemiology of asthma i n children and adults, the role of steroids in asthma management and n ew and novel asthma therapies. Specific chapters deal with the epidem iology of asthma mortality and of childhood asthma, others discuss the advantages and drawbacks of the use of b2-adenoreceptor agonists, cor ticosteroids, theophylline and new generation phosphodiesterase inhibi tors in the treatment of asthma. A new non-invasive method to assess a irway inflammation is also presented as well as steroid-sparing therap ies in asthma. The book addresses clinicians and basic scientists wit h an interest in asthma epidemiology, steroids and future therapies. I t is also of interest to clinical and no-clinical teachers in academic disciplines relating to respiratory disease.

IN THE WAR AGAINST DISEASES, THEY ARE THE SPECIAL FORCES.

They always keep a bag packed. They seldom have more than twenty-four hours' notice before they are dispatched. The phone calls that tell them to head to the airport, sometimes in the middle of the night, may give them no more information than the country they are traveling to and the epidemic they will tackle when they get there.

The universal human instinct is to run from an outbreak of disease. These doctors run toward it.

They are the disease detective corps of the U.S. Centers for Disease Control and Prevention (CDC), the federal agency that tracks and tries to prevent disease outbreaks and bioterrorist attacks around the world. They are formally called the Epidemic Intelligence Service (EIS) -- a group founded more than fifty years ago out of fear that the Korean War might bring the use of biological weapons -- and, like intelligence operatives in the traditional sense, they perform their work largely in anonymity. They are not household names, but over the years they were first to confront the outbreaks that became known as hantavirus, Ebola virus, and AIDS. Now they hunt down the deadly threats that dominate our headlines: West Nile virus, anthrax, and SARS.

In this riveting narrative, Maryn McKenna -- the only journalist ever given full access to the EIS in its fifty-three-year history -- follows the first class of disease detectives to come to the CDC after September 11, the first to confront not just naturally occurring outbreaks but the man-made threat of bioterrorism. They are talented researchers -- many with young families -- who trade two years of low pay and extremely long hours for the chance to be part of the group that has helped eradicate smallpox, push back polio, and solve the first major outbreaks of Legionnaires' disease, toxic shock syndrome, and "E. coli" O157.

Urgent, exhilarating, and compelling, "Beating Back the Devil" goes with the EIS as they try to stop epidemics -- before the epidemics stop us.

This volume addresses this need for sociological insight through empirically rich, theoretically innovative chapters that range across methods, traditions and foci in order to cast new light on the place, role and impact of neuroscience.

The purpose of this book is to examine the etiology of cancer in large human populations using mathematical models developed from an inter-disciplinary perspective of the population epidemiological, biodemographic, genetic and physiological basis of the mechanisms of cancer initiation and progression. In addition an investigation of how the basic mechanism of tumor initiation relates to general processes of senescence and to other major chronic diseases (e.g., heart disease and stroke) will be conducted.

The terrorist use of diseases as bioweapons has been one of the major security concerns in recent years, particularly after the anthrax letter attacks in the USA in 2001. This uncertain threat of intentional outbreaks of diseases exists side by side with the constantly changing very real threat from diseases, epidemics and pandemics as recently illustrated by the H1N1 influenza pandemic, SARS, and H5N1 bird influenza events. This publication contains case studies on the public health planning for (un)usual disease outbreaks for 11 large and small countries with a focus on South Eastern Europe. In many countries, military entities traditionally play an important role in emergency response to disease outbreaks. In smaller countries, very little exists, however, in terms of specific biopreparedness efforts (in both the military and civilian area), which is at least partly due to a relatively low bioterrorism threat perception, and serious resource constraints. The uncertainty associated with the bioterrorism threat makes public health preparedness planning for such events politically and financially very difficult. The similarity of responding to bioterrorism events and natural disease outbreaks from a public health point of view suggests the merit of looking at biopreparedness as a part of overall health emergency planning, not as a separate effort.

Mathematical epidemiology of infectious diseases usually involves describing the flow of individuals between mutually exclusive infection states. One of the key parameters describing the transition from the susceptible to the infected class is the hazard of infection, often referred to as the force of infection. The force of infection reflects the degree of contact with potential for transmission between infected and susceptible individuals. The mathematical relation between the force of infection and effective contact patterns is generally assumed to be subjected to the mass action principle, which yields the necessary information to estimate the basic reproduction number, another key parameter in infectious disease epidemiology. It is within this context that the Center for Statistics (CenStat, I-Biostat, Hasselt University) and the Centre for the Evaluation of Vaccination and the Centre for Health Economic Research and Modelling Infectious Diseases (CEV, CHERMID, Vaccine and Infectious Disease Institute, University of Antwerp) have collaborated over the past 15 years. This book demonstrates the past and current research activities of these institutes and can be considered to be a milestone in this collaboration. This book is focused on the application of modern statistical methods and models to estimate infectious disease parameters. We want to provide the readers with software guidance, such as R packages, and with data, as far as they can be made publicly available.

Neurologic and neuropsychiatric disorders are of great importance to societies and they also raise special considerations in epidemiological research methodology. Not only do neurologic and neuropsychiatric disorders form a major group of disorders associated with ageing populations, but those disorders that occur in earlier life can be associated with severe individual, family, and societal distress and burden. The inter-relationship of syndromes and disorders is a topic of major interest and growing biological insights across psychiatry and neurology. This includes not only overlaps in neurodegenerative syndromes but also those related to other systems such as metabolic, inflammatory, immune and vascular disorders. Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology is designed to focus on the overlaps and inter-relationships between neuro-epidemiological disorders, as well as on ways to harmonise large cohort studies to maximise opportunities for determining causes related to rarer disorders. Divided into three main parts, the book covers 1) the principles of neurologic and neuropsychiatric epidemiology; 2) specific neuropsychiatric disorders and their inter-relationships and 3) the implications of neuro-epidemiologic research for patient populations and current medical practice. This comprehensive work serves as an invaluable reference to current neuro-epidemiological methods for neurologists, psychiatrists, and senior trainees in those disciplines, as well as public health practitioners and students with an interest in neurology and neuropsychiatry.

Fertility and Pregnancy: An Epidemiologic Perspective, is a lively overview of human reproduction: how it works, and what causes it to go wrong. Weaving together history, biology, obstetrics, pediatrics, demography, infectious diseases, molecular genetics, and evolutionary biology, Allen Wilcox brings a fresh coherence to the epidemiologic study of reproduction and pregnancy. Along the way, he provides entertaining anecdotes, superb graphs, odd tidbits and occasional humor that bring the topic to life.
The book is divided into two sections. The first lays the foundations - the basic principles of reproductive physiology, demography, infectious diseases, and genetics as they apply to human reproduction. The second part deals with the endpoints of reproductive epidemiology - a spectrum ranging from infertility and fetal loss to birth defects and the delayed effects of fetal exposures. The book closes with a discussion of unsolved problems, suggesting possible research projects for a new generation of epidemiologists. An extensive glossary makes this a valuable reference as well as an enjoyable read.

The field of genetics is rapidly evolving and new medical breakthroughs are occuring as a result of advances in knowledge of genetics. This series continually publishes imporatnt reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.

This comprehensive, up-to-date volume defines the issues and offers potential solutions to the challenges of antimicrobial resistance. The chapter authors are leading international experts on antimicrobial resistance among a variety of bacteria, viruses including HIV and herpes, parasites and fungi. The chapters explore the molecular mechanisms of drug resistance, the immunology and epidemiology of resistance strains, clinical implications and implications on research and lack thereof, and prevention and future directions.

In recent years many introductory textbooks on clinical trial methodology have been published, some of which are excellent, in addition to a very extensive specialist literature. Nevertheless, here is a new book on methods and issues in clinical research. The objectives can be summarized in three points. 1. Integrate medical and statistical components of clinical research. 2. Do justice to the operational and practical requirements of clinical research. 3. Give space to the ethical implications of methodological issues in clinical research.

The scope of clinical research is to evaluate the effect of a treatment on the evolution of a disease in the human species. The treatment can be pharmacological, surgical, psychological/behavioral or organizational/logistic. The disease, intended as an impairment of a state of well-being or a condition capable of provoking such impairment over time, can be universally accepted as such (e.g. a cancer or a bone fracture) or perceived as such only by limited groups of individuals in a given cultural context (e.g. hair loss or weight gain). The course of the disease that ones wishes to change can be the one with no intervention or, more frequently, the one observed with the available treatment. The evaluation of the effect of a treatment on the course of a disease is a lengthy process, which progresses in increasingly complex stages.

A detailed coverage of the logistic, administrative and legal aspects of clinical research is outside the scope of this book. However, throughout the book we keep reminding the reader of these aspects because, as already mentioned, we firmly believe they have a crucial role in determining the success of a study. The history of clinical research is paved with relics of studies started with great pomp, riding great ideas and great hopes, which drowned miserably because of inadequate logistical preparation. In our experience, the excessive complexity of a clinical trial is the single most frequent cause of failure: the study is perfect on paper, but impossible to implement by patients and staff alike. The distance between the principal investigators and the reality of clinical research in its day-to-day practice is often the main cause of such disasters. We warmly encourage everyone involved in clinical research to get involved in the logistics of a study, learning from colleagues responsible for its practical conduct (clinical research associates, data managers, etc.) and to take part, in person, in the practical implementation of a trial before attempting to design a study protocol.

The book ends with a brief description of the drug development process and to the phases of clinical development.